Fusion Antibodies
Pre-clinicalFusion Antibodies offer a complete end-to-end service from antigen design to cell line development. R&D Antibody Discovery Partner.
Founded
2001
Focus
Antibodies
About
Fusion Antibodies offer a complete end-to-end service from antigen design to cell line development. R&D Antibody Discovery Partner.
Funding History
2Total raised: $9M
Grant$500KInnovate UKMar 15, 2021
IPO$8.5MUndisclosedJul 19, 2017
Company Info
TypePrivate
Founded2001
LocationBelfast, United Kingdom
StagePre-clinical
Contact
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile